Workshop: Can Innovative Formulations help reduce NHS Drug Wastage? 8th August, Chandos House, Royal Society of Medicine, 1800-2030 CPD Accredited
The Association of:
for better dosing, reduced wastage and better patient care
Since the 1930s, therapeutics have tended to be produced in tablet or capsule form as first target formulation. Although this formulation works well for many products – and is acceptable for many patients – studies suggest that around 37% of patients struggle to swallow tablets/capsules. For many patients with neurological conditions, the mechanics of swallowing can be impaired; for patients with psychiatric conditions part of the condition may involve poor insight about, or hostility to medication. Patients undergoing surgery or associated treatment to their throat area can suffer from subsequent swallowing difficulties as well. Percentages of patients struggling with these secondary swallowing difficulties can reach as high as 90% in subsets of patients with the primary neurological condition.
Many patients also struggle with other issues –
- Most people dislike injections
- Some struggle to coordinate breathing with metered dose inhalers
- Many dislike the bitter taste of most medicines
- Transdermal Patches can cause irritation
- Creams/Gels/Foams are messy
- Pessaries are unpleasant
- Intranasal sprays are uncomfortable
For prophylactic, daily therapy, this constant association of medication with an unpleasant activity can lead to a poor patient perception of medication, and subsequently lower levels of adherence.